SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-07-029146
Filing Date
2007-02-13
Accepted
2007-02-13 14:26:26
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G/A dsc13ga.htm SC 13G/A 42176
  Complete submission text file 0001193125-07-029146.txt   43910
Mailing Address 3151 SOUTH 17TH ST WILMINGTON NC 28412
Business Address 3151 SOUTH 17TH ST WILMINGTON NC 28412 9102510081
PHARMACEUTICAL PRODUCT DEVELOPMENT INC (Subject) CIK: 0001003124 (see all company filings)

IRS No.: 561640186 | State of Incorp.: NC | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-48083 | Film No.: 07608481
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address PPD INC 3151 17TH STREET EXTENSION WILMINGTON NC 28412
Business Address 9102510081
ESHELMAN FREDRIC N (Filed by) CIK: 0001033409 (see all company filings)

Type: SC 13G/A